» Articles » PMID: 28822081

Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche

Overview
Publisher Springer
Specialty Oncology
Date 2017 Aug 20
PMID 28822081
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The dual specificity phosphatases (DUSPs) constitute a family of stress-induced enzymes that provide feedback inhibition on mitogen-activated protein kinases (MAPKs) critical in key aspects of oncogenic signaling. While described in other tumor types, the landscape of DUSP mRNA expression in glioblastoma (GB) remains largely unexplored. Interrogation of the REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT) revealed induction (DUSP4, DUSP6), repression (DUSP2, DUSP7-9), or mixed (DUSP1, DUSP5, DUSP10, DUSP15) DUSP transcription of select DUSPs in bulk tumor specimens. To resolve features specific to the tumor microenvironment, we searched the Ivy Glioblastoma Atlas Project (Ivy GAP) repository, which highlight DUSP1, DUSP5, and DUSP6 as the predominant family members induced within pseudopalisading and perinecrotic regions. The inducibility of DUSP1 in response to hypoxia, dexamethasone, or the chemotherapeutic agent camptothecin was confirmed in GB cell lines and tumor-derived stem cells (TSCs). Moreover, we show that loss of DUSP1 expression is a characteristic of TSCs and correlates with expression of tumor stem cell markers in situ (ABCG2, PROM1, L1CAM, NANOG, SOX2). This work reveals a dynamic pattern of DUSP expression within the tumor microenvironment that reflects the cumulative effects of factors including regional ischemia, chemotherapeutic exposure among others. Moreover, our observation regarding DUSP1 dysregulation within the stem cell niche argue for its importance in the survival and proliferation of this therapeutically resistant population.

Citing Articles

Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms.

Ghazi B, Harmak Z, Rghioui M, Kone A, El Ghanmi A, Badou A Front Immunol. 2024; 15:1423232.

PMID: 39267734 PMC: 11390556. DOI: 10.3389/fimmu.2024.1423232.


Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations.

Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A World J Stem Cells. 2023; 15(5):302-322.

PMID: 37342224 PMC: 10277965. DOI: 10.4252/wjsc.v15.i5.302.


Current understanding of the human microbiome in glioma.

Liang J, Li T, Zhao J, Wang C, Sun H Front Oncol. 2022; 12:781741.

PMID: 36003766 PMC: 9393498. DOI: 10.3389/fonc.2022.781741.


Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance.

Singh M, Altameemi S, Lares M, Newton M, Setaluri V Sci Rep. 2022; 12(1):14395.

PMID: 35999349 PMC: 9399232. DOI: 10.1038/s41598-022-18578-x.


A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer.

Lu Y, Lian L, Shen X, Li Y, Ji S, Wang W Transl Cancer Res. 2022; 10(1):174-183.

PMID: 35116249 PMC: 8798931. DOI: 10.21037/tcr-20-2622.


References
1.
Meletis K, Wirta V, Hede S, Nister M, Lundeberg J, Frisen J . p53 suppresses the self-renewal of adult neural stem cells. Development. 2005; 133(2):363-9. DOI: 10.1242/dev.02208. View

2.
Lord C, Ashworth A . The DNA damage response and cancer therapy. Nature. 2012; 481(7381):287-94. DOI: 10.1038/nature10760. View

3.
Liu Y, Wang J, Guo J, Wu J, Lieberman H, Yin Y . DUSP1 is controlled by p53 during the cellular response to oxidative stress. Mol Cancer Res. 2008; 6(4):624-33. DOI: 10.1158/1541-7786.MCR-07-2019. View

4.
Waha A, Felsberg J, Hartmann W, von dem Knesebeck A, Mikeska T, Joos S . Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Res. 2010; 70(4):1689-99. DOI: 10.1158/0008-5472.CAN-09-3218. View

5.
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View